Prevagen Maker Faces FTC and New York Claims Challenge

Quincy Bioscience (Wisconsin) failed to dismiss a lawsuit in which the Federal Trade Commission (FTC) and New York attorney general said it deceptively marketed the dietary supplement Prevagen by claiming it improved memory, despite a lack of scientific evidence. In a decision released on July 25, U.S. District Judge Louis Stanton in Manhattan rejected Quincy’s ...